Lafutidine
SIGMA/SML1611 - ≥98% (HPLC)
Synonym: (Z)
CAS Number: 118288-08-7
Empirical Formula (Hill Notation): C22H29N3O4S
Molecular Weight: 431.55
MDL Number: MFCD00867520
Linear Formula: C22H29N3O4S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C22H29N3O4S/c26-21(18- |
| InChI key | KMZQAVXSMUKBPD-DJWKRKHSSA |
| Quality Level | 100 ![]() |
| SMILES string | O=C(CS(CC1=CC=CO1)=O)NC/C |
| solubility | DMSO: 20 mg/mL, clear |
| storage temp. | −20°C |
| Biochem/physiol Actions: | Lafutidine is a second generation H2 histamine receptor antagonist. |
| Biochem/physiol Actions: | Lafutidine is a second generation H2 histamine receptor antagonist. Lafutidine has been used clinically to treat ulcers and gastro-esophageal reflux disease (GERD). Lafutidine has also been investigated as a treatment against peripheral neuropathy and for its protective stomach effects during cancer chemotherapies and long term ibuprofen use. |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P301 + P312 + P330 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |


